Search hospitals > Rhode Island > Providence
Roger Williams Medical Center
Claim this profileProvidence, Rhode Island 02908
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Human Immunodeficiency Virus Infection
100 reported clinical trials
1 medical researcher
Summary
Roger Williams Medical Center is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Human Immunodeficiency Virus Infection and other specialties. Roger Williams Medical Center is involved with conducting 100 clinical trials across 144 conditions. There are 1 research doctors associated with this hospital, such as Ritesh Rathore.Area of expertise
1Cancer
Global LeaderStage II
Stage I
Stage III
2Breast Cancer
Global LeaderPR positive
ER positive
HER2 negative
Top PIs
Clinical Trials running at Roger Williams Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Cancer
ALK Gene Rearrangement
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Roger Williams Medical Center?
Roger Williams Medical Center is a medical facility located in Providence, Rhode Island. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Human Immunodeficiency Virus Infection and other specialties. Roger Williams Medical Center is involved with conducting 100 clinical trials across 144 conditions. There are 1 research doctors associated with this hospital, such as Ritesh Rathore.